Skip to main content
CYDY logo

CYDY · CytoDyn Inc.

Track CYDY — free
$0.25 +0.01 (+3.67%) At close · Aug 26
Market Cap
$327.85M
Shares
1.37B

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Mr. Cohen Resigned 2025-05-06
Robert E. Hoffman Appointed 2025-05-06
Antonio Migliarese Resigned 2024-01-29
Mitchell Cohen Appointed 2024-01-29
Mitchell Cohen Appointed 2024-01-29
Jacob P. Lalezari Appointed 2024-01-29
Jacob P. Lalezari, M.D. Appointed 2023-11-21
Cyrus Arman Appointed 2023-07-11
Cyrus Arman Resigned 2023-07-11
Antonio Migliarese Appointed 2023-05-24
Scott A. Kelly M.D. Resigned 2022-12-19
Nitya G. Ray, Ph.D. Resigned 2022-11-25
Stephen M. Simes Appointed 2022-10-19
Scott A. Kelly, M.D. Resigned 2022-10-19
Ryan Dunlap Appointed 2022-08-30
Antonio Migliarese Resigned 2022-06-30
Cyrus Arman Appointed 2022-06-30
Jordan G. Naydenov Resigned 2022-05-23
Karen J. Brunke, Ph.D. Appointed 2022-03-30
Tanya Durkee Urbach Appointed 2022-01-27
Scott A. Kelly, M.D. Resigned 2022-01-27
Nader Z. Pourhassan, Ph.D. Resigned 2022-01-27
Nader Z. Pourhassan, Ph.D. Terminated 2022-01-27
Harish Seethamraju, M.D. Resigned 2021-12-21
Gordon A. Gardiner Appointed 2021-07-06
Key facts CIK 1175680 CUSIP 23283M101 13F (30d) 4 filings 4 filers Visit website Investor relations